The Influence of Influenza Virus Infections in Patients with Chronic Obstructive Pulmonary Disease

References

• Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007;29(6):1224–1238. doi:10.1183/09031936.00109906
   PubMed Web of Science ®Google Scholar
• Dransfield MT, Kunisaki KM, Strand MJ, et al. Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(3):324–330. doi:10.1164/rccm.201605-1014OC
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-8
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–852. doi:10.1136/thorax.57.10.847
   PubMed Web of Science ®Google Scholar
• Liang L, Shang Y, Xie W, Shi J, Tong Z, Jalali MS. Trends in hospitalization expenditures for acute exacerbations of COPD in Beijing from 2009 to 2017. Int J Chron Obstruct Pulmon Dis. 2020;15:1165–1175. doi:10.2147/COPD.S243595
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Anzueto A. Role of infection in exacerbations of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2015;21:278–283. doi:10.1097/MCP.0000000000000154
   PubMed Web of Science ®Google Scholar
• Mohan A, Chandra S, Agarwal D, et al. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review. Respirology. 2010;15:536–542. doi:10.1111/j.1440-1843.2010.01722.x
   PubMed Web of Science ®Google Scholar
• Wang H, Anthony D, Selemidis S, Vlahos R, Bozinovski S. Resolving viral-induced secondary bacterial infection in COPD: a concise review. Front Immunol. 2018;9:2345. doi:10.3389/fimmu.2018.02345
   PubMed Web of Science ®Google Scholar
• Lanska DJ, Hoffmann RG. Seasonal variation in stroke mortality rates. Neurology. 1999;52:984–990. doi:10.1212/WNL.52.5.984
   PubMed Web of Science ®Google Scholar
• Beasley V, Joshi PV, Singanayagam A, et al. Lung microbiology and exacerbations in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:555–569. doi:10.2147/COPD.S28286
   PubMed Web of Science ®Google Scholar
• Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest. 2000;117(Suppl 2):380S–385S. doi:10.1378/chest.117.5_suppl_2.380S
   PubMed Web of Science ®Google Scholar
• Singanayagam A, Joshi PV, Mallia P, Johnston SL. Viruses exacerbating chronic pulmonary disease: the role of immune modulation. BMC Med. 2012;10:27. doi:10.1186/1741-7015-10-27
   PubMed Web of Science ®Google Scholar
• Rohde G, Borg I, Wiethege A, et al. Inflammatory response in acute viral exacerbations of COPD. Infection. 2008;36(5):427–433. doi:10.1007/s15010-008-7327-5
   PubMed Web of Science ®Google Scholar
• Seemungal T, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(9):1618–1623. doi:10.1164/ajrccm.164.9.2105011
   PubMed Web of Science ®Google Scholar
• Frickmann H, Jungblut S, Hirche TO, Groß U, Kuhns M, Zautner AE. The influence of virus infections on the course of COPD. Eur J Microbiol Immunol. 2012;2(3):176–185. doi:10.1556/EuJMI.2.2012.3.2
   Google Scholar
• Zwaans WA, Mallia P, van Winden ME, Rohde GG. The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease—a systematic review. J Clin Virol. 2014;61(2):181–188. doi:10.1016/j.jcv.2014.06.025
   PubMed Web of Science ®Google Scholar
• McManus TE, Marley AM, Baxter N, et al. Respiratory viral infection in exacerbations of COPD. Respir Med. 2008;102:1575–1580. doi:10.1016/j.rmed.2008.06.006
   PubMed Web of Science ®Google Scholar
• Rohde G, Wiethege A, Borg I, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case–control study. Thorax. 2003;58:37–42. doi:10.1136/thorax.58.1.37
   PubMed Web of Science ®Google Scholar
• Poole PJ, Chacko E, Wood-Baker RW, et al. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev;2006. CD002733. doi:10.1002/14651858.CD002733.pub2
   PubMed Web of Science ®Google Scholar
• Gorse GJ, Otto EE, Daughaday CC, et al. Influenza virus vaccination of patients with chronic lung disease. Chest. 1997;112:1221–1233. doi:10.1378/chest.112.5.1221
   PubMed Web of Science ®Google Scholar
• Nath KD, Burel JG, Shankar V, et al. Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:51–56. doi:10.2147/COPD.S53590
   PubMed Web of Science ®Google Scholar
• Wongsurakiat P, Maranetra KN, Wasi C, et al. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest. 2004;125(6):2011–2020. doi:10.1378/chest.125.6.2011
   PubMed Web of Science ®Google Scholar
• Yap FH, Ho PL, Lam KF, Chan PK, Cheng YH, Peiris JS. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol. 2004;73(4):617–623. doi:10.1002/jmv.20135
   PubMed Web of Science ®Google Scholar
• McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol. 2014;12:252–262. doi:10.1038/nrmicro3231
   PubMed Web of Science ®Google Scholar
• Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA. 2013;309:275–282. doi:10.1001/jama.2012.194139
   PubMed Web of Science ®Google Scholar
• Smith AM, Adler FR, Ribeiro RM, et al. Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae. PLoS Pathog. 2013;9:e1003238. doi:10.1371/journal.ppat.1003238
   PubMed Web of Science ®Google Scholar
• McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19:571–582. doi:10.1128/CMR.00058-05
   PubMed Web of Science ®Google Scholar
• Cheng YH, You SH, Lin YJ, et al. Mathematical modeling of post-coinfection with influenza A virus and Streptococcus pneumoniae, with implications for pneumonia and COPD-risk assessment. Int J Chron Obstruct Pulmon Dis. 2017;12:1973–1988. doi:10.2147/COPD.S138295
   PubMed Web of Science ®Google Scholar
• Bosch AA, Biesbroek G, Trzcinski K, et al. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog. 2013;9:e1003057. doi:10.1371/journal.ppat.1003057
   PubMed Web of Science ®Google Scholar
• McNamee LA, Harmsen AG. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun. 2006;74:6707–6721. doi:10.1128/IAI.00789-06
   PubMed Web of Science ®Google Scholar
• Singanayagam A, Singanayagam A, Elder DHJ, et al. Is community-acquired pneumonia an independent risk factor for cardiovascular disease? Eur Respir J. 2012;39:187–196. doi:10.1183/09031936.00049111
   PubMed Web of Science ®Google Scholar
• Toschke AM, Heuschmann PU, Wood O, Wolfe CD. Temporal relationship between influenza infections and subsequent first-ever stroke incidence. Age Ageing. 2009;38:100–103. doi:10.1093/ageing/afn232
   PubMed Web of Science ®Google Scholar
• Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611–2618. doi:10.1056/NEJMoa041747
   PubMed Web of Science ®Google Scholar
• Kulick ER, Alvord T, Canning M, et al. Risk of stroke and myocardial infarction after influenza-like illness in New York State. BMC Public Health. 2021;21(1):864. doi:10.1186/s12889-021-10916-4
   PubMed Web of Science ®Google Scholar